2036 - Baby Becomes First to Receive Gene Therapy for DyslexiaNew
York (AP): December 18, 2036
Today marks the beginning of a new age in
educational therapy. At 11:30 AM, the soon-to-be child of Jake and Lauren Talman
became the first ever to receive in utero treatment for the learning disorder
known as dyslexia.
The most common symptom of dyslexia is the tendency
to see letters or words in a different order than they are actually written.
Those affected often have trouble reading and therefore may not take in
information as quickly as people without the disorder.
pinpointed the set of genes responsible for dyslexia in August of 2033 and
immediately began work on a replacement therapy. Trials proved unsuccessful
however, until this past summer, when researchers at the University of Illinois
discovered a more effective method of introducing the foreign genes into the
Doctors hope this will serve as a model for treatment
of other disorders, such as dyspraxia (affects motor functions) and dysgraphia
(affects writing ability).
No complications were encountered during the
procedure, and Mrs. Talman is reported in excellent condition. The baby is due